menu

Tailoring Treatment Plans for HER2+ Metastatic Breast Cancer

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Tailoring Treatment Plans for HER2+ Metastatic Breast Cancer

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Overview

    With many effective treatments available for HER2+ metastatic breast cancer, it’s important to focus on a patient’s quality of life through tailored treatment plans. Dive in to review the data from recent trials and learn about ongoing studies as well with Dr. Charles Turck as he speaks with Dr. Adam Brufsky, Professor of Medicine and Associate Chief for the Division of Hematology Oncology at the University of Pittsburgh School of Medicine's Department of Medicine, and Dr. Sara Chumsri, Professor of Oncology at the Mayo Clinic Cancer Center in Jacksonville, Florida, where she's also the Mayo Clinic Breast Disease Group Research Co-Chair and HER2 Working Group Co-Chair.

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Overview

    With many effective treatments available for HER2+ metastatic breast cancer, it’s important to focus on a patient’s quality of life through tailored treatment plans. Dive in to review the data from recent trials and learn about ongoing studies as well with Dr. Charles Turck as he speaks with Dr. Adam Brufsky, Professor of Medicine and Associate Chief for the Division of Hematology Oncology at the University of Pittsburgh School of Medicine's Department of Medicine, and Dr. Sara Chumsri, Professor of Oncology at the Mayo Clinic Cancer Center in Jacksonville, Florida, where she's also the Mayo Clinic Breast Disease Group Research Co-Chair and HER2 Working Group Co-Chair.

Facebook Comments

Schedule22 Jun 2024